ab469 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab469 は 41 報の論文で使用されています。

  • Dallaglio K  et al. Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion. Br J Cancer 110:199-207 (2014). WB ; Human . PubMed: 24196791
  • Chen HA  et al. Clinical significance of survivin expression in patients with urothelial carcinoma. Dis Markers 2014:574985 (2014). IHC-P ; Human . PubMed: 24648609
  • Xu YX  et al. Differential expression and function of survivin during the progress of pterygium. Invest Ophthalmol Vis Sci 55:8480-7 (2014). PubMed: 25468890
  • Shimizu Y  et al. BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. PLoS One 7:e34102 (2012). IHC-P ; Mouse . PubMed: 22511931
  • Pandiri AR  et al. Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer. Toxicol Pathol 40:1141-59 (2012). PubMed: 22688403
  • Kaminskyy VO  et al. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Carcinogenesis 32:1450-8 (2011). PubMed: 21771726
  • Ait-Mohamed O  et al. Acetonic extract of Buxus sempervirens induces cell cycle arrest, apoptosis and autophagy in breast cancer cells. PLoS One 6:e24537 (2011). PubMed: 21935420
  • Dallaglio K  et al. Endogenous survivin modulates survival and proliferation in UVB-treated human keratinocytes. Exp Dermatol 18:464-71 (2009). WB ; Human . PubMed: 19320741
  • Ferri F  et al. Non-coding murine centromeric transcripts associate with and potentiate Aurora B kinase. Nucleic Acids Res 37:5071-80 (2009). WB, RIP ; Mouse . PubMed: 19542185
  • Bourguignon LY  et al. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microrna-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 284:26533-46 (2009). WB ; Human . PubMed: 19633292
  • Platani M  et al. The Nup107-160 nucleoporin complex promotes mitotic events via control of the localization state of the chromosome passenger complex. Mol Biol Cell 20:5260-75 (2009). ICC/IF ; Human . PubMed: 19864462
  • Maerki S  et al. The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone microtubules in anaphase and is required for cytokinesis. J Cell Biol 187:791-800 (2009). ICC/IF ; Human . PubMed: 19995937
  • Lampiasi N  et al. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. Mol Pharmacol 76:290-300 (2009). PubMed: 19461054
  • Kwong J  et al. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Mol Cancer Ther 8:1893-905 (2009). PubMed: 19567818
  • Benedetti V  et al. Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds. Mol Cancer Ther 7:679-87 (2008). WB ; Human . PubMed: 18347153
  • Pellizzaro C  et al. Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report. Pancreas 36:e15-23 (2008). WB ; Human . PubMed: 18437074
  • Donovan MH  et al. Dynamic expression of TrkB receptor protein on proliferating and maturing cells in the adult mouse dentate gyrus. Hippocampus 18:435-9 (2008). PubMed: 18240316
  • Dance-Barnes ST  et al. Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors. Toxicol Appl Pharmacol 231:77-84 (2008). IHC-P ; Mouse . PubMed: 18565564
  • Végran F  et al. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Oncogene 26:290-7 (2007). PubMed: 16847456
  • Hinnis AR  et al. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer 96:639-45 (2007). PubMed: 17285125
  • Barnes N  et al. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer 94:253-8 (2006). IHC-P ; Human . PubMed: 16421596
  • Klein UR  et al. Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Mol Biol Cell 17:2547-58 (2006). PubMed: 16571674
  • Colnaghi R  et al. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281:33450-6 (2006). PubMed: 16950794
  • Santini D  et al. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients. Clin Cancer Res 11:3784-9 (2005). PubMed: 15897577
  • Rödel F  et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65:4881-7 (2005). IHC-P ; Human . PubMed: 15930309
  • Zanchi C  et al. Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839. Cancer Res 65:2364-72 (2005). WB ; Human . PubMed: 15781651
  • Branca M  et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 124:113-21 (2005). IHC-P . PubMed: 15923164
  • Sommer KW  et al. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22:4266-80 (2003). PubMed: 12833149
  • Kennedy SM  et al. Prognostic importance of survivin in breast cancer. Br J Cancer 88:1077-83 (2003). PubMed: 12671708
  • Grabowski P  et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88:115-9 (2003). PubMed: 12556969
  • Miranda MB  et al. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 17:390-400 (2003). PubMed: 12592339
  • Mahotka C  et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9:1334-42 (2002). PubMed: 12478470
  • Chakravarti A  et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-8 (2002). PubMed: 11844831
  • Fortugno P  et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115:575-85 (2002). PubMed: 11861764
  • Giodini A  et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62:2462-7 (2002). PubMed: 11980633
  • Yu J  et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87:91-7 (2002). PubMed: 12085263
  • O'Connor DS  et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2:43-54 (2002). PubMed: 12150824
  • Blanc-Brude OP  et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8:987-94 (2002). PubMed: 12172543
  • Qanungo S  et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 21:4149-57 (2002). PubMed: 12037671
  • Zhu L  et al. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 508:369-74 (2001). PubMed: 11728454
  • Wheatley SP  et al. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr Biol 11:886-90 (2001). PubMed: 11516652

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"